Trial Profile
Phase II trial of ITX 5061 in treatment-naive and previously treated patients with hepatitis C.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2011
Price :
$35
*
At a glance
- Drugs ITX 5061 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors iTherX Pharmaceuticals
- 04 Feb 2009 New trial record.